Clinical and nutritional correlates of bacterial diarrhoea aetiology in young children: a secondary cross-sectional analysis of the ABCD trial

BMJ Paediatr Open. 2024 Apr 11;8(1):e002448. doi: 10.1136/bmjpo-2023-002448.

Abstract

Objective: The objective was to assess the association between nutritional and clinical characteristics and quantitative PCR (qPCR)-diagnosis of bacterial diarrhoea in a multicentre cohort of children under 2 years of age with moderate to severe diarrhoea (MSD).

Design: A secondary cross-sectional analysis of baseline data collected from the AntiBiotics for Children with Diarrhoea trial (NCT03130114).

Patients: Children with MSD (defined as >3 loose stools within 24 hours and presenting with at least one of the following: some/severe dehydration, moderate acute malnutrition (MAM) or severe stunting) enrolled in the ABCD trial and collected stool sample.

Study period: June 2017-July 2019.

Interventions: None.

Main outcome measures: Likely bacterial aetiology of diarrhoea. Secondary outcomes included specific diarrhoea aetiology.

Results: A total of 6692 children with MSD had qPCR results available and 28% had likely bacterial diarrhoea aetiology. Compared with children with severe stunting, children with MAM (adjusted OR (aOR) (95% CI) 1.56 (1.18 to 2.08)), some/severe dehydration (aOR (95% CI) 1.66 (1.25 to 2.22)) or both (aOR (95% CI) 2.21 (1.61 to 3.06)), had higher odds of having likely bacterial diarrhoea aetiology. Similar trends were noted for stable toxin-enterotoxigenic Escherichia coli aetiology. Clinical correlates including fever and prolonged duration of diarrhoea were not associated with likely bacterial aetiology; children with more than six stools in the previous 24 hours had higher odds of likely bacterial diarrhoea (aOR (95% CI) 1.20 (1.05 to 1.36)) compared with those with fewer stools.

Conclusion: The presence of MAM, dehydration or high stool frequency may be helpful in identifying children with MSD who might benefit from antibiotics.

Keywords: epidemiology; infant.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections*
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Dehydration / complications
  • Dehydration / drug therapy
  • Diarrhea / complications
  • Diarrhea / microbiology
  • Dysentery* / complications
  • Dysentery* / drug therapy
  • Growth Disorders / complications
  • Growth Disorders / drug therapy
  • Humans
  • Infant

Substances

  • Anti-Bacterial Agents

Associated data

  • ClinicalTrials.gov/NCT03130114